September 1, 2007 -- A diagnosis of type 2 diabetes can be devastating for the individual and their family. Furthermore, many people with diabetes fear insulin...
July 15, 2006 -- Insulin detemir (Levemir) joins insulin glargine (Lantus) as the only other long-acting insulin analogue approved as basal therapy for the treatment...
March 11, 2008 -- Phase 2A Trials Planned For Second Quarter 2008 JERUSALEM -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB http://www.oramed.com), a developer of...
June 9, 2008 -- Results from a 24-week multi-center, randomized, open-label study presented at ADA 2008 SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Amylin...
November 15, 2007 -- JERUSALEM -- Oramed Pharmaceuticals, Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral delivery systems, is pleased to announce that it...
April 1, 2001 -- Novo Nordisk Pharmaceuticals, Denmark, received clearance from the Food and Drug Administration to market its Innovo Dial-a-Dose insulin injection...
December 22, 2003 -- When Sidnee Mercer was diagnosed with Type 1 diabetes at age 8, her family didn't dwell in the land of "why me?" Instead, they quickly learned all...
May 15, 2007 -- Insulin inhalation powder (exubera), also called inhaled insulin, is a dry powder form of rapid-acting insulin delivered by oral inhalation. It is...
May 1, 2008 -- Despite the clinically significant improvments in HbA that can result from initiating insulin therapy in people with type 2 diabetes whose glycaemia...
May 1, 2008 -- Baseline characteristics in the participants receiving insulin detemir (n=291) were comparable with those of the insulin glargine group (n=291). (4)...